| APRE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the APRE shares outstanding history going back to 10/3/2019:
Also see: APRE Market Cap History APRE YTD Return |
APRE Shares Outstanding History — Aprea Therapeutics Share Count Over Time
As of 8/12/2026 Aprea Therapeutics has 12.59 million APRE shares outstanding. Investors often track the APRE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows APRE share count trends over time, with 31 historical shares outstanding datapoints presented, dating back to 10/3/2019.
| APRE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
APRE Historical Shares Outstanding: +45.49% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| APRE Stock Price Chart |
| About Aprea Therapeutics Inc |
| Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality. Co.'s advanced synthetic lethality product candidate is ATRN-119, a clinical-stage small molecule inhibitor of ataxia telangiectasia and Rad3-related (ATR) a kinase that plays a critical role in DNA damage response (DDR). ATR and Checkpoint Kinase 1 are critical DDR kinases that prevent the collapse of replication forks into DNA double-strand breaks. It has completed all IND enabling studies for its oral, small molecule WEE1 inhibitor, APR-1051, and received U.S. Food and Drug Administration (FDA) clearance of its IND. We show 31 historical shares outstanding datapoints in our coverage of APRE's shares outstanding history. Understanding the changing numbers of APRE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like APRE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching APRE by allowing them to research APRE shares outstanding history as well as any other stock in our coverage universe. |
| APRE Current Stock Quote |
Quotes delayed 20 minutes  Free APRE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| APRE Share Performance |
| Shares Outstanding Peers |
| Aprea Therapeutics (APRE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
APRI Shares Outstanding History APTX Shares Outstanding History APVO Shares Outstanding History APYX Shares Outstanding History AQST Shares Outstanding History AQXP Shares Outstanding History ARA Shares Outstanding History ARAV Shares Outstanding History ARAY Shares Outstanding History ARCT Shares Outstanding History More Healthcare companies » |
APRE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
